Language Select


Recent News
Apr 27, 2017

Varian Medical Systems (NYSE: VAR) will demonstrate its full range of radiation oncology delivery systems at the 36th ESTRO (European Society for Radiotherapy & Oncology) meeting, taking place in...

Apr 26, 2017

Varian Medical Systems (NYSE:VAR) today is reporting GAAP net earnings from continuing operations of $0.74 per diluted share and non-GAAP net earnings from continuing operations of $0.89 per...

Apr 5, 2017

Varian Medical Systems (NYSE: VAR) today announced it has named Gary E. Bischoping, Jr. of Dell Technologies as Chief Financial Officer effective May 8, 2017. Bischoping, 49, will replace Elisha...

More news >

Recent Blog Posts
Apr 25, 2017Spot ON
Varian’s Particle Therapy division will be showcasing the latest in proton therapy solutions at the Annual Meetings of ESTRO and PTCOG in May.
Read more
Apr 11, 2017Spot ON
The University of Texas MD Anderson Cancer Center recently presented data at the 2017 Multidisciplinary Thoracic Cancers Symposium which shows early promise for the treatment of recurrent lung cancer with advanced form of proton therapy.
Read more
Mar 28, 2017Spot ON
As more and more proton centers come online, the need for training remains high. In response to the increased demands for continued education, Varian developed a hands-on course using the Eclipse™ Treatment Planning System for Proton Therapy.
Read more
Corporate Communications Contacts
Spencer Sias
Vice President, Corporate Communications and Investor Relations
Mark Plungy
Director, Public Relations
Neil Madle
Director, Corporate Communications/Investor Relations, Europe
+44 (0)7786 526 068
  • Follow Us

Production of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.